Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FBLN4 Antikörper

FBLN4 Reaktivität: Human WB, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN317833
  • Target Alle FBLN4 Antikörper anzeigen
    FBLN4 (Fibulin 4 (FBLN4))
    Reaktivität
    • 64
    • 22
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 62
    • 3
    Kaninchen
    Klonalität
    • 64
    • 1
    Polyklonal
    Konjugat
    • 30
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser FBLN4 Antikörper ist unkonjugiert
    Applikation
    • 54
    • 27
    • 27
    • 15
    • 13
    • 13
    • 7
    • 6
    • 6
    • 5
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Spezifität
    This antibody detects endogenous levels of Fibulin-4 protein.(region surrounding Asp123)
    Aufreinigung
    Affinity Purified
    Top Product
    Discover our top product FBLN4 Primärantikörper
  • Applikationshinweise
    ELISA: 1: 10000approx. 1: 20000. WB: 1: 500approx. 1: 1000. IHC: 1: 50approx. 1: 200.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    PBS, pH 7.2, 0.05 % sodium azide
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    FBLN4 (Fibulin 4 (FBLN4))
    Andere Bezeichnung
    Fibulin-4 (FBLN4 Produkte)
    Synonyme
    CB257 antikoerper, fbln4 antikoerper, fc56c09 antikoerper, id:ibd2923 antikoerper, sb:cb257 antikoerper, wu:fc56c09.x1 antikoerper, ARCL1B antikoerper, FBLN4 antikoerper, MBP1 antikoerper, UPH1 antikoerper, 0610011K11Rik antikoerper, Fbln4 antikoerper, FIBL-4 antikoerper, Fibulin-4 antikoerper, H411 antikoerper, EGF-containing fibulin-like extracellular matrix protein 2 antikoerper, EGF containing fibulin-like extracellular matrix protein 2b antikoerper, fibulin 4 antikoerper, EGF containing fibulin like extracellular matrix protein 2 antikoerper, epidermal growth factor-containing fibulin-like extracellular matrix protein 2 antikoerper, Efemp2 antikoerper, efemp2b antikoerper, fbln4 antikoerper, EFEMP2 antikoerper
    Hintergrund
    A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein encoded by this gene contains four EGF2 domains and six calcium binding EGF2 domains. This gene is necessary for elastic fiber formation and connective tissue development. Defects in this gene are cause of an autosomal recessive cutis laxa syndrome.Synonyms: EFEMP2, EGF-containing fibulin-like extracellular matrix protein 2, FBLN4, Fibulin 4, Protein UPH1, UNQ200/PRO226
    Molekulargewicht
    approx. 50 kDa
    Gen-ID
    30008
    NCBI Accession
    NP_058634
    UniProt
    O95967
Sie sind hier:
Kundenservice